Chemotherapy-Induced Peripheral Neuropathy Market to Witness Significant Growth at a CAGR of 14.2% During the Forecast Period (2026-2036) as Novel Therapies Enter Late-Stage Development | DelveInsight

The growing market of chemotherapy-induced peripheral neuropathy is driven by high prevalence, significant unmet need, and the increasing use of neurotoxic chemotherapies. Growing emphasis on survivorship and quality of life, along with the emergence of mechanism-based, disease-modifying...